Roleda, Grace M.
HRN: 18-39-35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/11/2022
CEFTRIAXONE 1G (VIAL)
11/11/2022
11/17/2022
IVT
2gms
Od
Acute Cystitis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Choice Wrong Choice
Overall appropriateness: No Wrong Choice